BiPar Sciences

Developer of PARP inhibitors as cancer therapies (acq. by Sanofi)

AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.

1300 El Camino Real, Suite 100
Menlo Park, CA 94025
650.621.8808